PBD150   Click here for help

GtoPdb Ligand ID: 8356

Synonyms: compound 53 [PMID 16420052]
PDB Ligand
Compound class: Synthetic organic
Comment: PBD150 is a potent inhibitor of glutaminyl cyclase (QC), an enzyme which can modify the N-terminal glutamate residue of amyloid beta (Aβ) proteins to generate pyroglutamate-Aβ [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 92.43
Molecular weight 320.13
XLogP 1.67
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cc(ccc1OC)NC(=S)NCCCn1cncc1
Isomeric SMILES COc1cc(ccc1OC)NC(=S)NCCCn1cncc1
InChI InChI=1S/C15H20N4O2S/c1-20-13-5-4-12(10-14(13)21-2)18-15(22)17-6-3-8-19-9-7-16-11-19/h4-5,7,9-11H,3,6,8H2,1-2H3,(H2,17,18,22)
InChI Key FZQXMGLQANXZRP-UHFFFAOYSA-N
References
1. Buchholz M, Heiser U, Schilling S, Niestroj AJ, Zunkel K, Demuth HU. (2006)
The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship.
J Med Chem, 49 (2): 664-77. [PMID:16420052]
2. Cynis H, Scheel E, Saido TC, Schilling S, Demuth HU. (2008)
Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta.
Biochemistry, 47 (28): 7405-13. [PMID:18570439]
3. Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, Tayler K, Wiltgen B, Hatami A, Rönicke R et al.. (2012)
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nature, 485 (7400): 651-5. [PMID:22660329]